Presentation TCT 2019 TCT 48: Bioresorbable Scaffold Versus Metallic Drug-Eluting Stent in Patients at High Risk of Restenosis (COMPARE-ABSORB trial) : Very late device thrombosis while on extended DAPT Presenter: Robert-Jan Van Geuns September 25, 2019
Presentation TCT 2019 TCT 47: Five-Year Clinical Outcomes From Randomized Comparison of Everolimus-Eluting Bioresorbable Vascular Scaffolds Versus Everolimus-Eluting Metallic Stents in Patients With Coronary Artery Disease From ABSORB China Trial Presenter: Run-Lin Gao September 25, 2019
Presentation TCT 2019 TCT 46: FANTOM II trial: Safety & Performance Study of the Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold – First Report on Initial 48 Month Outcomes Presenter: Alexandre Abizaid September 25, 2019
Presentation TCT 2019 TCT 45: Safety and Performance of the Resorbable Magnesium Scaffold, Magmaris in a Real World Setting - First Cohort Subjects at 12-month Follow-up of the BIOSOLVE-IV Registry Presenter: Stefan Verheye September 25, 2019
Presentation TCT 2019 TCT 44: Impact of Stent Edge Hinging on Chronic Neointimal Hyperplasia after Newer Generation Drug-Eluting Stent Placement in RCA Presenter: Takahiro Jimba September 25, 2019
Presentation TCT 2019 TCT 11: Everolimus-eluting Bioresorbable Scaffolds versus Drug-eluting Stents in Patients with Acute Myocardial Infarction – 2-Year Results of the Randomized ISAR-Absorb MI Trial Presenter: Jens Wiebe September 25, 2019
Presentation TCT 2019 TCT 43: A Prospective Randomized Multicenter Study to Assess the Safety and Effectiveness of the Orsiro Sirolimus Eluting Stent in the Treatment of Subjects with up to two de novo Coronary Artery Lesions – BIOFLOW IV: 4 Years Clinical Results Presenter: Bernhard Witzenbichler September 25, 2019
Presentation TCT 2019 TCT 42: Polymer-free Drug-coated vs. Bare-metal Coronary Stents in Patients Undergoing Non-cardiac Surgery A Subgroup Analysis of the LEADERS FREE Trial Presenter: Abdelhakim Allali September 25, 2019
Presentation TCT 2019 Industry Perspective on Drug-Eluting Technologies Guidance Presenter: Mark Pacyna September 25, 2019
Presentation TCT 2019 TCT 41: A prospective multicentre randomized all-comers trial to assess the safety and effectiveness of the ultra-thin-strut sirolimus-eluting coronary stent Supraflex: 2-year results of the TALENT trial Presenter: Azfar Zaman September 25, 2019
Presentation TCT 2019 FDA Perspective and Revised Guidance Presenter: Eleni Whatley September 25, 2019
Presentation TCT 2019 New Data Regarding Drug-Eluting Technologies Presenter: Krishna Rocha-Singh September 25, 2019
Presentation TCT 2019 An Unforeseen Setback: Summary Level Meta-Analysis Brings Practice Back to the 1990s. Presenter: Michael Jaff September 25, 2019
Presentation TCT 2019 Case Example: Contemporary DES Thrombosis Presenter: Amir Darki September 25, 2019
Presentation TCT 2019 Drug-Eluting Stent Thrombosis and Restenosis: Mechanisms, Frequency, and Treatment Presenter: Binita Shah September 25, 2019
Presentation TCT 2019 Case Example: Complex DES With Long-Term Outcomes Presenter: Anita Paggi September 25, 2019
Presentation TCT 2019 Drug-Eluting Stent Platforms and Outcomes 2019 Presenter: Roberto Diletti September 25, 2019
Presentation TCT 2019 Drug-Coated Balloons: State of the Art in the Face of Controversy Presenter: Antonio Colombo September 25, 2019
News Analysis Hints at Survival Benefit With Revascularization in Stable Patients With Myocardial Ischemia Michael O'Riordan September 24, 2019